Compare Stocks: MRAI, VMD, TACO, and BDSX

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
BDSX Biodesix	$27.72 +1.4%	$25.93	$5.26 ▼ $31.97	$292.47M	0.56	91,080 shs	124,290 shs
MRAI Marpai	$3.43 +4.1%	$2.69	$0.22 ▼ $4.16	$92.34M	4.73	69,586 shs	4,455 shs
TACO Berto Acquisition	$10.46 -0.1%	$10.46	$10.11 ▼ $10.65	$341.26M	0.08	55,064 shs	41,477 shs
VMD Viemed Healthcare	$9.13 +0.6%	$9.38	$6.05 ▼ $12.61	$347.74M	1.04	255,149 shs	387,732 shs

(Almost) Everything You Need To Know About The EV Market

Looking to profit from the electric vehicle mega-trend? Click the link to see our list of which EV stocks show the most long-term potential.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
BDSX Biodesix	+1.43%	-4.74%	+2.06%	+26.06%	+261.41%
MRAI Marpai	+4.07%	+8.54%	+38.59%	+388.60%	+150.36%
TACO Berto Acquisition	-0.10%	+0.10%	-0.19%	-0.57%	+0.58%
VMD Viemed Healthcare	+0.55%	+2.47%	+1.67%	-24.04%	+31.75%

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
BDSX Biodesix	$27.72 +1.4%	$25.93	$5.26 ▼ $31.97	$292.47M	0.56	91,080 shs	124,290 shs
MRAI Marpai	$3.43 +4.1%	$2.69	$0.22 ▼ $4.16	$92.34M	4.73	69,586 shs	4,455 shs
TACO Berto Acquisition	$10.46 -0.1%	$10.46	$10.11 ▼ $10.65	$341.26M	0.08	55,064 shs	41,477 shs
VMD Viemed Healthcare	$9.13 +0.6%	$9.38	$6.05 ▼ $12.61	$347.74M	1.04	255,149 shs	387,732 shs

(Almost) Everything You Need To Know About The EV Market

Looking to profit from the electric vehicle mega-trend? Click the link to see our list of which EV stocks show the most long-term potential.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
BDSX Biodesix	+1.43%	-4.74%	+2.06%	+26.06%	+261.41%
MRAI Marpai	+4.07%	+8.54%	+38.59%	+388.60%	+150.36%
TACO Berto Acquisition	-0.10%	+0.10%	-0.19%	-0.57%	+0.58%
VMD Viemed Healthcare	+0.55%	+2.47%	+1.67%	-24.04%	+31.75%

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
BDSX Biodesix	2.80	Moderate Buy	$35.00	26.26% Upside
MRAI Marpai	0.00	N/A	N/A	N/A
TACO Berto Acquisition	1.00	Sell	N/A	N/A
VMD Viemed Healthcare	2.25	Hold	$14.00	53.34% Upside

Current Analyst Ratings Breakdown

Latest MRAI, VMD, TACO, and BDSX Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
9/25/2026	BDSX Biodesix	HC Wainwright Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Buy	$27.00 ➝ $38.00
9/8/2026	BDSX Biodesix	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Upgrade	Sell (E+) ➝ Sell (D-)
8/24/2026	TACO Berto Acquisition	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Upgrade	Sell (D-) ➝ Sell (D)
8/24/2026	VMD Viemed Healthcare	Barrington Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Initiated Coverage	Outperform	$14.00
8/21/2026	BDSX Biodesix	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Downgrade	Sell (D-) ➝ Sell (E+)
8/17/2026	VMD Viemed Healthcare	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Downgrade	Buy (B-) ➝ Hold (C+)
8/10/2026	BDSX Biodesix	Canaccord Genuity Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Boost Price Target	Buy	$27.00 ➝ $35.00
8/6/2026	BDSX Biodesix	HC Wainwright Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Buy	$26.00 ➝ $27.00
8/5/2026	VMD Viemed Healthcare	Freedom Capital Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Downgrade	Strong-Buy ➝ Hold
8/3/2026	VMD Viemed Healthcare	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Upgrade	Hold (C+) ➝ Buy (B-)
7/17/2026	VMD Viemed Healthcare	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Hold (C+)

(Data available from 10/3/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
BDSX Biodesix	$102.94M	2.84	N/A	N/A	($0.31) per share	-89.42
MRAI Marpai	$34.87M	2.65	N/A	N/A	($1.72) per share	-1.99
TACO Berto Acquisition	N/A	N/A	N/A	N/A	N/A	N/A
VMD Viemed Healthcare	$301.61M	1.15	$1.16 per share	7.89	$3.78 per share	2.42

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
BDSX Biodesix	-$35.26M	-$3.17	N/A	N/A	N/A	-26.97%	-788.19%	-30.33%	11/2/2026 (Estimated)
MRAI Marpai	-$28.75M	-$0.77	N/A	N/A	N/A	-85.70%	N/A	-100.23%	11/11/2026 (Estimated)
TACO Berto Acquisition	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
VMD Viemed Healthcare	$14.93M	$0.36	25.36	19.02	2.24	4.81%	10.16%	7.22%	11/4/2026 (Estimated)

Latest MRAI, VMD, TACO, and BDSX Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
8/14/2026	Q2 2026	TACO Berto Acquisition	N/A	$0.03	N/A	$0.03	N/A	N/A
8/5/2026	Q2 2026	BDSX Biodesix	-$0.9018	-$0.71	+$0.1918	-$0.71	$26.03 million	$26.86 million
8/3/2026	Q2 2026	VMD Viemed Healthcare	$0.12	$0.07	-$0.05	$0.07	$78.00 million	$78.10 million

Compare Dividends

Company	Annual Payout	Dividend Yield	5-Year Annualized Dividend Growth	Payout Ratio	Years of Consecutive Growth
BDSX Biodesix	N/A	N/A	N/A	N/A	N/A
MRAI Marpai	N/A	N/A	N/A	N/A	N/A
TACO Berto Acquisition	$0.16	1.53%	N/A	N/A	N/A
VMD Viemed Healthcare	N/A	N/A	N/A	N/A	N/A

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
BDSX Biodesix	5.12	2.85	2.85
MRAI Marpai	N/A	0.82	0.82
TACO Berto Acquisition	N/A	N/A	N/A
VMD Viemed Healthcare	0.04	1.13	1.02

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
BDSX Biodesix	20.96%
MRAI Marpai	49.75%
TACO Berto Acquisition	N/A
VMD Viemed Healthcare	74.24%

Insider Ownership

Company	Insider Ownership
BDSX Biodesix	23.20%
MRAI Marpai	46.10%
TACO Berto Acquisition	13.20%
VMD Viemed Healthcare	20.60%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
BDSX Biodesix	334	10.55 million	8.10 million	No Data
MRAI Marpai	150	26.92 million	5.61 million	No Data
TACO Berto Acquisition	7,892	32.63 million	28.32 million	No Data
VMD Viemed Healthcare	1,382	38.09 million	30.24 million	Not Optionable

MRAI, VMD, TACO, and BDSX Headlines

Recent News About These Companies

Viemed Healthcare, Inc. $VMD Shares Newly Bought by Bank of America Corp DE

October 2 at 3:12 AM | marketbeat.com

Viemed Healthcare (VMD) Stock Fair Value Rises After Mixed Analyst Views On Profitability

September 4, 2026 | finance.yahoo.com

Viemed Healthcare, Inc. (VMD) Q2 2026 Earnings Call Transcript

August 4, 2026 | seekingalpha.com

Viemed Healthcare, Inc. (VMD) Lags Q2 Earnings Estimates

August 3, 2026 | zacks.com

Viemed Healthcare Announces Second Quarter 2026 Financial Results

August 3, 2026 | accessnewswire.comA

Viemed Healthcare Announces Second Quarter 2026 Earnings Conference Call Details

July 21, 2026 | accessnewswire.comA

Viemed Healthcare (NASDAQ:VMD) Insider William Frazier Sells 10,000 Shares

June 27, 2026 | insidertrades.com

Viemed Healthcare Releases Updated Investor Presentation and Outlook

June 5, 2026 | theglobeandmail.com

Stonegate Capital Partners Updates Coverage on Viemed Healthcare, Inc. (VMD) 1Q26

May 12, 2026 | newsfilecorp.comN

Viemed Healthcare, Inc. (VMD) Q1 2026 Earnings Call Transcript

May 6, 2026 | seekingalpha.com

Viemed (VMD) Q1 2026 Earnings Transcript

May 6, 2026 | fool.com

Viemed Healthcare, Inc. (VMD) Q1 Earnings Miss Estimates

May 5, 2026 | zacks.com

Viemed Healthcare Announces First Quarter 2026 Financial Results

May 5, 2026 | accessnewswire.comA

Viemed Healthcare Announces First Quarter 2026 Earnings Conference Call Details

April 21, 2026 | accessnewswire.comA

Viemed Healthcare (NASDAQ:VMD) President Sells $297,389.40 in Stock

March 21, 2026 | insidertrades.com

Viemed Healthcare to Present at Sidoti's Small-Cap Virtual Investor Conference March 18-19

March 16, 2026 | accessnewswire.comA

Stonegate Capital Partners Updates Coverage on Viemed Healthcare, Inc. (VMD) 4Q 2025

March 11, 2026 | newsfilecorp.comN

Viemed Healthcare, Inc. (NASDAQ:VMD) Q4 2025 earnings call transcript

March 6, 2026 | msn.com

Viemed Healthcare, Inc. (VMD) Q4 2025 Earnings Call Transcript

March 5, 2026 | seekingalpha.com

Viemed Healthcare Announces 2026 Share Repurchase Program

March 4, 2026 | accessnewswire.comA

Viemed Healthcare Announces Record 2025 Financial Results

March 4, 2026 | accessnewswire.comA

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All

MRAI, VMD, TACO, and BDSX Company Descriptions

Biodesix NASDAQ:BDSX

$27.72 +0.39 (+1.43%)

Closing price 10/2/2026 04:00 PM Eastern

Extended Trading

$27.77 +0.05 (+0.18%)

As of 10/2/2026 07:55 PM Eastern

Biodesix, Inc. operates as a data-driven diagnostic solutions company in the United States. The company offers blood-based lung tests, including Nodify XL2 and Nodify CDT tests, together marketed as part of Nodify Lung Nodule Risk Assessment testing strategy, to assess the risk of lung cancer and help in identifying the appropriate treatment pathway and help physicians in reclassifying risk of malignancy in patients with suspicious lung nodules. It also provides GeneStrat ddPCR and NGS, and VeriStrat tests, which are used in the diagnosis of lung cancer to measure the presence of mutations in the tumor and the state of the patient's immune system to establish the patient's prognosis and help guide treatment decisions. In addition, the company, through its partnership with Bio-Rad Laboratories, Inc., provides Bio-Rad SARS-CoV-2 ddPCR, a COVID-19 Test under Biodesix WorkSafe testing program; and Platelia SARS-CoV-2 Total Ab test, an antibody test for detecting a B-cell immune response to SARS-CoV-2 that indicate recent or prior infection. Further, it offers diagnostic and clinical research, as well as clinical trial testing services to biopharmaceutical companies; and discovers, develops, and commercializes companion diagnostics. The company was formerly known as Elston Technologies, Inc. and as changed to Biodesix, Inc. in 2006. Biodesix, Inc. was incorporated in 2005 and is headquartered in Louisville, Colorado.

Marpai NASDAQ:MRAI

$3.43 +0.13 (+4.07%)

As of 10/2/2026 02:49 PM Eastern

Marpai, Inc., a technology-driven healthcare payer, focuses on providing services to the self-insured employer market in the United States and Israel. The company offers ancillary services, such as care management, case management, actuarial services, bill review and cost containment services. Marpai, Inc. was incorporated in 2021 and is based in Tampa, Florida.

Berto Acquisition NASDAQ:TACO

$10.46 -0.01 (-0.10%)

Closing price 10/2/2026 03:59 PM Eastern

Extended Trading

$10.46 +0.00 (+0.05%)

As of 10/2/2026 04:10 PM Eastern

Del Taco Restaurants, Inc. develops, franchises, owns, and operates Del Taco quick-service Mexican-American restaurants in the United States. The company's restaurants offer Mexican inspired and American classic dishes. As of August 31, 2021, it operated approximately 600 restaurants across 16 states. The company was founded in 1964 and is headquartered in Lake Forest, California.

Viemed Healthcare NASDAQ:VMD

$9.13 +0.05 (+0.55%)

Closing price 10/2/2026 04:00 PM Eastern

Extended Trading

$9.14 +0.00 (+0.05%)

As of 10/2/2026 04:27 PM Eastern

Viemed Healthcare, Inc., together with its subsidiaries, provides home medical equipment (HME) and post-acute respiratory healthcare services to patients in the United States. It provides respiratory disease management solutions, including treatment of chronic obstructive pulmonary disease (COPD), which include non-invasive ventilation, percussion vests, and other therapies; and invasive and non-invasive ventilation and related equipment and supplies to patients suffering from COPD. The company leases non-invasive and invasive ventilators, positive airway pressure machines (PAP), durable medical equipment, percussion vests, oxygen concentrators, and other medical equipment; and sells and rents HME devices. In addition, it provides neuromuscular care and oxygen therapy services; and sleep apnea management provides sleep solutions and/or equipment, such as PAP, automatic continuous positive airway pressure, and bi-level positive airway pressure machines. Further, the company offers in home sleep apnea testing services, as well as healthcare staffing and recruitment services. Viemed Healthcare, Inc. was founded in 2006 and is headquartered in Lafayette, Louisiana.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest MRAI, VMD, TACO, and BDSX Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest MRAI, VMD, TACO, and BDSX Earnings

Compare Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

MRAI, VMD, TACO, and BDSX Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

MRAI, VMD, TACO, and BDSX Company Descriptions

Biodesix NASDAQ:BDSX

Marpai NASDAQ:MRAI

Berto Acquisition NASDAQ:TACO

Viemed Healthcare NASDAQ:VMD

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest MRAI, VMD, TACO, and BDSX Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest MRAI, VMD, TACO, and BDSX Earnings

Compare Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

MRAI, VMD, TACO, and BDSX Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

MRAI, VMD, TACO, and BDSX Company Descriptions

Biodesix NASDAQ:BDSX

Marpai NASDAQ:MRAI

Berto Acquisition NASDAQ:TACO

Viemed Healthcare NASDAQ:VMD

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools